US Patent 8258130 Pyrimidine hydrazide compounds as PGDS inhibitors
Patent 8258130 was granted and assigned to Sanofi on September, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+71 characters)
Article
Patent abstract
This invention is directed to a compound of formula (I):
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08258130 Pyrimidine hydrazide compounds as PGDS inhibitors US Patent 8258130 Pyrimidine hydrazide compounds as PGDS inhibitors
Infobox
Patent Number
0825813000
Patent Number
825813000
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082581300
Date of Patent
September 4, 2012
0Patent Application Number
125703550
Date Filed
September 30, 2009
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082581300
Date of Patent
September 4, 2012
0Patent Application Number
125703550
Date Filed
September 30, 2009
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08258130 Pyrimidine hydrazide compounds as PGDS inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08258130
Date of patent
September 4, 2012
Patent application number
12570355
Date Filed
September 30, 2009
Patent primary examiner
Find more entities like US Patent 8258130 Pyrimidine hydrazide compounds as PGDS inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
